Dr. Holman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17837 First Avenue South
Suite 6
Normandy Park, WA 98148Phone+1 206-412-5347
Summary
- Stress kills. Immuno-autonomics activates immune function to drive autoimmune diseases to excess. I founded Inmedix to stratify and address adverse autonomic nervous system (ANS) profile with next-generation heart rate variability (HRV). Contact me or visit www.inmedix.com if you want to know more. Thanks.
Education & Training
- University of WashingtonFellowship, Rheumatology, 1990 - 1992
- HCA HealthONE/Sky Ridge Medical CenterResidency, Internal Medicine, 1987 - 1990
- University of Missouri-Columbia School of MedicineClass of 1987
- Bowdoin CollegeAB, Chemistry, Magna Cum Laude, 1977 - 1981
- Thacher Schooldiploma, 1973 - 1977
Certifications & Licensure
- WA State Medical License 1990 - 2025
Awards, Honors, & Recognition
- President Northwest Rheumatism Society, 2005
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 45 citationsHeart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritisAndrew J. Holman, Edmund Ng
Autonomic Neuroscience. 2008-12-05 - 23 citationsAn Elephant Among Us: The Role of Dopamine in the Pathophysiology of FibromyalgiaPatrick B. Wood, Andrew J. Holman
The Journal of Rheumatology. 2009-02-01 - 61 citationsSodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-contr...I. Jon Russell, Andrew J. Holman, Todd J. Swick, Sarah Alvarez-Horine, Y. Grace Wang
Pain. 2011-05-01
Press Mentions
- Inmedix Raises $31,470 to Support Kids with Arthritis at Seattle Children’s HospitalSeptember 15th, 2021
- Inmedix, a Boutique Biotech Company, Is Now Working on Commercializing Its Second Major Patent. The First Patent Was Acquired by a Large Pharmaceutical Company at an Historic ValuationJuly 18th, 2019
- Inmedix CEO to Co-Chair Immuno-Autonomics Study Group at 2018 Annual Meeting of the American College of RheumatologyOctober 20th, 2018
- Join now to see all
Professional Memberships
- Fellow
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: